WallStreetZenWallStreetZen

NASDAQ: ZCMD
Zhongchao Inc Stock

$1.04+0.00 (+0%)
Updated Jun 5, 2023
ZCMD Price
$1.04
Fair Value Price
$1.59
Market Cap
$240.88M
52 Week Low
$0.60
52 Week High
$1.40
P/E
-9.2x
P/B
8.05x
P/S
2.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$14.15M
Earnings
-$2.94M
Gross Margin
44.9%
Operating Margin
-18.86%
Profit Margin
-20.8%
Debt to Equity
0.19
Operating Cash Flow
-$662k
Beta
0.3
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ZCMD Overview

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ZCMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ZCMD ($1.04) is undervalued by 34.58% relative to our estimate of its Fair Value price of $1.59 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ZCMD ($1.04) is significantly undervalued by 34.58% relative to our estimate of its Fair Value price of $1.59 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ZCMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ZCMD due diligence checks available for Premium users.

Be the first to know about important ZCMD news, forecast changes, insider trades & much more!

ZCMD News

Valuation

ZCMD fair value

Fair Value of ZCMD stock based on Discounted Cash Flow (DCF)
Price
$1.04
Fair Value
$1.59
Undervalued by
34.58%
ZCMD ($1.04) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ZCMD ($1.04) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ZCMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ZCMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-9.2x
Industry
6.73x
Market
53.21x

ZCMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.05x
Industry
3.51x
ZCMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ZCMD's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ZCMD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ZCMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$38.6M
Liabilities
$5.6M
Debt to equity
0.19
ZCMD's short-term assets ($22.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZCMD's short-term assets ($22.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZCMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ZCMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
ZCMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ZCMD vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
ZCMD$240.88M+0.29%-9.20x8.05x
OPRX$251.61M+0.62%-18.59x2.03x
SY$222.97M0.00%-157.14x0.64x
SOPH$268.54M-5.64%-3.29x1.45x
NUTX$302.02M+1.77%-0.67x3.26x

Zhongchao Stock FAQ

What is Zhongchao's quote symbol?

(NASDAQ: ZCMD) Zhongchao trades on the NASDAQ under the ticker symbol ZCMD. Zhongchao stock quotes can also be displayed as NASDAQ: ZCMD.

If you're new to stock investing, here's how to buy Zhongchao stock.

What is the 52 week high and low for Zhongchao (NASDAQ: ZCMD)?

(NASDAQ: ZCMD) Zhongchao's 52-week high was $1.40, and its 52-week low was $0.60. It is currently -25.71% from its 52-week high and 73.33% from its 52-week low.

How much is Zhongchao stock worth today?

(NASDAQ: ZCMD) Zhongchao currently has 231,617,461 outstanding shares. With Zhongchao stock trading at $1.04 per share, the total value of Zhongchao stock (market capitalization) is $240.88M.

Zhongchao stock was originally listed at a price of $4.00 in Feb 24, 2020. If you had invested in Zhongchao stock at $4.00, your return over the last 3 years would have been -74%, for an annualized return of -36.17% (not including any dividends or dividend reinvestments).

How much is Zhongchao's stock price per share?

(NASDAQ: ZCMD) Zhongchao stock price per share is $1.04 today (as of Jun 5, 2023).

What is Zhongchao's Market Cap?

(NASDAQ: ZCMD) Zhongchao's market cap is $240.88M, as of Jun 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Zhongchao's market cap is calculated by multiplying ZCMD's current stock price of $1.04 by ZCMD's total outstanding shares of 231,617,461.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.